Secondary Logo

Journal Logo

Articles by Yves Lévy

Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients

Thiébaut, Rodolphe; Hue, Sophie; Le Marec, Fabien; More

AIDS. 31(17):2355-2365, November 13, 2017.

Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease

Borges, Álvaro H.; Weitz, Jeffrey I.; Collins, Gary; More

AIDS. 28(12):1791-1796, July 31st, 2014.

Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers

Richert, Laura; Hue, Sophie; Hocini, Hakim; More

AIDS. 27(9):1421-1431, June 1st, 2013.

Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03A adjuvant in HIV-1-infected adults

Durier, Christine; Desaint, Corinne; Lucht, Frédéric; More

AIDS. 27(1):87-93, January 2nd, 2013.

Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV

Lévy, Yves; Thiébaut, Rodolphe; Gougeon, Marie-Lise; More

AIDS. 26(6):711-720, March 27th, 2012.

Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial

Salmon-Céron, Dominique; Durier, Christine; Desaint, Corinne; More

AIDS. 24(14):2211-2223, September 10th, 2010.

Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients

Viard, Jean-Paul; Fagard, Catherine; Chaix, Marie-Laure; More

AIDS. 23(11):1383-1388, July 17th, 2009.

Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults

Lesprit, Philippe; Pédrono, Gaëlle; Molina, Jean-Michel; More

AIDS. 21(18):2425-2434, November 30th, 2007.

Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048–079 Trials)*

Durier, Christine; Capitant, Catherine; Lascaux, Anne-Sophie; More

AIDS. 21(14):1887-1897, September 2007.

Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals

Lévy, Yves; Durier, Christine; Lascaux, Anne-Sophie; More

AIDS. 20(3):405-413, February 14th, 2006.

Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients

Lévy, Yves; Gahéry-Ségard, Hanne; Durier, Christine; More

AIDS. 19(3):279-286, February 18th, 2005.